The patient showed signs of muscle weakness and fatigue, likely caused by critically low potassium levels hypokalemia. Muscle cramps and spasms also occurred due to hypophosphatemia and hypokalemia. The patient’s Hypomagnesemia and Hypocalcaemia led to muscle twitching. The patient experienced excessive urination and thirst, likely due to impaired kidney function and an imbalance of acids and bases in the blood. This imbalance, combined with electrolyte disturbances, caused persistent fatigue, weakness, and lethargy. The patient's blood pressure was low, due to impaired kidney function and electrolyte imbalances. Additionally, the patient was at risk of developing brittle bones and fractures due to disrupted calcium and magnesium metabolism. The patient was also diagnosed with Rickets, due to low vitamin D levels and impaired calcium metabolism. Despite electrolyte disturbances, the patient's adrenal gland function appeared normal, as indicated by normal hormone levels. Electrolyte imbalances include hyponatremia, hypophosphatemia, and low urinary potassium excretion, contributing to muscle weakness, fatigue, and cardiac arrhythmias. The patient was treated with multiple potassium correction till normal serum potassium level is achieved.
Gitelman Syndrome is a rare autosomal recessive disorder caused by mutation in SLC12A3 gene leading to impaired salt re-absorption in the distal convoluted tubule.
1 Characterized by hypokalemic metabolic alkalosis, low urinary calcium levels, and magnesium deficiency
2,3, this condition typically manifests during late childhood or early adulthood. Gitelman Syndrome is particularly a defect in the apical thiazide sensitive sodium chloride cotransporter (NCCT) in the distal tubules.
4
The laboratory findings presented exhibit a characteristic profile of electrolyte and metabolic disturbances, aligning with the diagnostic criteria for Gitelman Syndrome, a rare genetic disorder. A prominent feature of this condition is the severe potassium deficiency, with a serum potassium level of 1.95 mmol/L; which accompanied by a notable magnesium deficiency, with a serum magnesium level of 1.4 mEq/L. The observed low calcium level of 8.3 mg/dl, in conjunction with normal renal function, suggests impaired urinary calcium excretion, a hallmark feature of Gitelman Syndrome. Furthermore, the presence of respiratory alkalosis , as indicated by the ABG report showing compensated metabolic acidosis hypokalemia, and hypomagnesemia, is consistent with this condition.
5
Normal renal function is supported by a serum creatinine level of 0.64 mg/dl and an elevated glomerular filtration rate (GFR) of 133 mL/min/1.73m
2. Additionally, the severe deficiency of 25-OH vitamin D3, with a level of 8.1 ng/ml, aligns with the expected biochemical profile of Gitelman Syndrome. Electrolyte imbalances, including hyponatremia, hypophosphatemia, and low urinary potassium excretion, are also characteristic of this condition. Thyroid function tests revealed an elevated thyroid-stimulating hormone (TSH) level of 8.490 µIU/mL, with normal triiodothyronine (T3) and
Thyroxine (T4) levels, suggesting subclinical hypothyroidism. Although thyroid dysfunction is not a characteristic feature of Gitelman Syndrome, it can occur in patients with this condition, possibly due to electrolyte imbalances.
Adrenocorticotropic hormone (ACTH) levels in Gitelman Syndrome patients often fall within normal ranges or are slightly elevated. The observed
ACTH value of 21.9 pg/mL aligns with this trend, suggesting that normal
ACTH levels do not preclude a diagnosis of Gitelman Syndrome. Instead, diagnosis relies on a comprehensive evaluation of clinical presentation, electrolyte imbalances. Furthermore, stress triggered by electrolyte disturbances or other complications may influence
ACTH levels, although this stress response does not necessarily translate to elevated
ACTH levels. In terms of cortisol regulation, Gitelman Syndrome typically spares adrenal function, leading to expected normal cortisol levels. Cortisol production is regulated by the hypothalamic-pituitary-adrenal (HPA) axis, the hypothalamic-pituitary-adrenal (HPA) axis remains intact in Gitelman Syndrome, ensuring that patients' adrenal glands respond appropriately to stress, maintaining normal cortisol levels.
In summary, the laboratory findings presented are consistent with Gitelman Syndrome, characterized by FTT adolescent with severe hypokalemia, hypomagnesemia, impaired urinary calcium excretion, and metabolic alkalosis, along with supporting features such as normal kidney function, low vitamin D levels, normal
ACTH levels, and electrolyte imbalances. The patient was given discharge on Vitamin D, Magnesium and
Thyroxine Orally after she had recovered from hypokalemia. Hypokalemia can be a complex condition to treat when it's associated with a genetic syndrome, such as Gitelman or Bartter syndrome. The presence of an underlying genetic defect or physiological imbalance often makes it difficult to completely cure hypokalemia. Hypokalemia associated with a syndrome can be considered a manageable condition, rather than one that can be completely cured.
References : |
- Şahin B, Büberci R. Does Gitelman syndrome really save bone? Intercont J Int Med. 2024; 2(1):26-28.
- Nelson Textbook of Pediatrics, 21st edition (2020). Chapter 521: Gitelman Syndrome. (pg. 2634-2636).
- Nelson Textbook of Pediatrics, 21st edition (2020). Chapter 522: Bartter Syndrome and Gitelman Syndrome. (pp. 2637-2640).
- Ghai Essential Pediatrics, 8th Edition (2013) CBS Publication and distribution Pvt. Ltd. Chapter 16: Disorder of Kidney and Urinary tract (Pg. 506).
- IAP Textbook of Paediatics, Jaypee Brothers Medical Pubishers(P)Ltd, Fifth edition(2013). Chapter 10: Disease of Kidney and Urinary tract, 10.11: Renal tubular disease (Pg. 651).
|